
FOXO1-IN-8
CAS No. ——
FOXO1-IN-8( FOXO1 inhibitor 8 )
Catalog No. M16924 CAS No. ——
A small molecule, selective FOXO1 inhibitor that inhibits FOXO-dependent glucose production devoid of lipogenic activity in hepatocytes.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameFOXO1-IN-8
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small molecule, selective FOXO1 inhibitor that inhibits FOXO-dependent glucose production devoid of lipogenic activity in hepatocytes.
-
DescriptionA small molecule, selective FOXO1 inhibitor that inhibits FOXO-dependent glucose production devoid of lipogenic activity in hepatocytes; shows beneficial effects of FOXO1 inhibition on diabetic hyperglycemia by reducing hepatic glucose production.
-
In Vitro——
-
In Vivo——
-
SynonymsFOXO1 inhibitor 8
-
PathwayNuclear Receptor/Transcription Factor
-
TargetFoxo1
-
RecptorFoxo1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight243.27
-
Molecular FormulaC12H13N5O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILES——
-
Chemical Name2-(2-(methylamino)pyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Langlet F, et al. Cell. 2017 Nov 2;171(4):824-835.e18.
molnova catalog



related products
-
FOXO1-IN-8
A small molecule, selective FOXO1 inhibitor that inhibits FOXO-dependent glucose production devoid of lipogenic activity in hepatocytes.
-
JY-2
JY-2 is an orally active and selective forkhead transcription factor O1 (FoxO1) inhibitor with antidiabetic activity and inhibits FoxO1 transcription.JY-2 can be used to study psoriasis and diabetes.
-
AS-1842856
A novel transcription factor Foxo1 inhibitor that potently and selectively inhibits Foxo1-mediated transactivation with IC50 of 33 nM.